Reportedly, 3–15% of patients with RA were positive for anti-Ro/SS-A antibodies, which might be positive in rheumatic diseases other than SS and RA, such as systemic lupus erythematosus [27], dermatomyositis (DM) [28], and systemic sclerosis [29]. Here, CALR is linked to systemic sclerosis.